Table 5 The incidence of adverse events.

From: Determination of the median effective dose of sufentanil combined with remimazolam in inhibiting tracheal intubation response

Adverse events

Negative (n = 14)

Positive (n = 13)

P

Hypertension, n(%)

0 (0%)

5 (38.5%)

0.038

Hypotension, n(%)

4 (28.6%)

1(7.7%)

0.468

Bradycardia, n(%)

2 (14.3%)

0

0.496

Tachycardia, n(%)

0 (0%)

2(15.4%)

0.43

Hypoxaemia, n(%)

0 (0%)

0 (0%)

/

Injection pain, n(%)

0 (0%)

0 (0%)

/

Body movement, n(%)

0 (0%)

1 (7.7%)

0.97

  1. Data are presented as mean ± SD or number (percentage of patients).
Back to article page